Section 17-105-108 - Prescriptive authority(a)(1) Physicians supervising physician assistants may delegate prescriptive authority to physician assistants to include receiving, prescribing, ordering, and administering Schedules II-V controlled substances as described in the Uniform Controlled Substances Act, § 5-64-101 et seq., and 21 C.F.R. Part 1300, all legend drugs, and all nonschedule prescription medications and medical devices.(2) A physician assistant's prescriptive authority extends to drugs listed in Schedule II only if the prescription is for:(A) An opioid, if the prescription is only for a five-day period or less; or(B) A stimulant, if the prescription meets the following criteria:(i) The prescription was originally initiated by a physician;(ii) The physician has evaluated the patient within six (6) months before the physician assistant issues a prescription; and(iii) The prescription by the physician assistant is to treat the same condition as the original prescription.(b) A physician assistant may prescribe hydrocodone combination products reclassified from Schedule III to Schedule II as of October 6, 2014, if authorized by the physician assistant's supervising physician and in accordance with other requirements of this section.(c) At no time shall a physician assistant's level of prescriptive authority exceed that of the supervising physician.(d) Physician assistants who prescribe controlled substances shall register with the United States Drug Enforcement Administration as part of the United States Drug Enforcement Administration's Mid-Level Practitioner Registry, 21 C.F.R. Part 1300, 58 FR 31171-31175, and the Controlled Substances Act.(e) The Arkansas State Medical Board shall promptly adopt rules concerning physician assistants that are consistent with the board's rules governing the prescription of dangerous drugs and controlled substances by physicians.Amended by Act 2021, No. 634,§ 10, eff. 7/28/2021.Amended by Act 2015, No. 529,§ 2, eff. 7/22/2015.